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ERRATUM Open Access
Erratum to: Clinical trial and in-vitro study
comparing the efficacy of treating bony
lesions with allografts versus synthetic or
highly-processed xenogeneic bone grafts
Eva Johanna Kubosch1, Anke Bernstein1, Laura Wolf1, Tobias Fretwurst2, Katja Nelson2 and Hagen Schmal1,3,4*
Erratum
After publication of the original article [1], the authors
noticed an error in the ‘Methods’ section. Within the
‘Patients’ sub-section, the first item in the list of syn-
thetic or highly processed xenogeneic bone substitutes
(SBS) should have been given as Orthoss®, rather than
BioOss®. The sentence should therefore have read as
follows:
“The following SBS were used: Orthoss® (Geistlich,
Wolhusen, Switzerland) in 41.4 %, and at clearly lower
percentages, respectively: Norian SRS® (Synthes) (8.6 %),
Chronos® (Synthes) (1.7 %), Atlantik® (Argomedical) (2.6 %),
Alaska® (Argomedical) (0.9 %), Endobone® (Biomet) (4.3 %),
Pyrost® (Stryker) (0.9 %), Nanostim® (Medtronic) (37.1 %),
Actifuse® (Baxter) (0.9 %), Tutobone® (Novomedics) (0.9 %)
and PerOssal® (Botiss) (0.9 %).”
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